基于3,5-二胺基-N（N′,N′-正二丁基甲酰胺基苯基）-苯甲酰胺的聚酰亚胺的溶解性、热稳定性和取向性能

用制得的大体积双侧基3,5-二胺基-N（N′,N′-正二丁基甲酰胺基苯基）-苯甲酰胺（DAPDM）,与3,3′-二甲基-4,4′-二氨基二苯甲烷(DMMDA)、3,3′,4,4′-二苯醚四甲酸二酐(ODPA)采用一步法共缩聚制得聚酰亚胺共聚物。采用核磁共振对该共聚物进行了表征,对其溶解性、热稳定性、预倾角进行了分析。结果表明：制备的聚酰亚胺可溶于氮甲基吡咯烷酮（NMP）、二甲基甲酰胺（DMF）等溶剂,溶解性良好,并且聚酰亚胺膜具有2.8°的预倾角。     

对苯醌二亚胺与吡啶共聚物的金属配合物催化法合成及性能

在二氯-1,3双(二苯基磷)丙烷基镍(Ⅱ)存在下,通过N,N′-二氯苯醌二亚胺和2,5-二甲基N, N′- 二氯苯醌二亚胺与2,5-二溴吡啶的格氏(Grignard) 试剂共聚,得到了两种新型共轭聚合物。采用FT-IR、1HNMR、 UVVis、XRD、循环伏安、充放电对共聚物进行结构与性能测试。结果表明：该类共聚物具有一定的电化学活性,每种聚合物均在-1.0～2.0 V 出现一对氧化还原峰。聚（N,N′二氯苯醌二亚胺吡啶）和聚（2,5二甲基N, N′二氯苯醌二亚胺吡啶)的比电容分别为126 F/g和63 F/g。     

新型可溶性含氟聚芳醚酮的合成与性能

以双酚AF、1,4-二（4′-氟苯酰基）苯或1,3-二（4′-氟苯酰基）苯为单体,通过亲核取代反应缩聚合成了2种新型含氟聚芳醚酮,由此显著改善了加工性能。采用FTIR、1HNMR、GPC、DSC、TGA等方法对聚合物的结构和性能进行了分析和表征。研究了聚合物的热性能、溶解性、材料拉伸性和介电性。结果表明：2种聚芳醚酮均具有较高的分子量（Mn>6.24×104）;玻璃化转变温度Tg分别为174 ℃和162 ℃,空气中失重5%的温度分别为525 ℃和507 ℃;室温下在N甲基吡咯烷酮（NMP）、二甲基乙酰胺（DMAc）、四氢呋喃（THF）等有机溶剂中均有良好的溶解性,并且可浇铸成有韧性的透明薄膜,薄膜的拉伸强度分别为98 MPa和93 MPa。1 MHz下薄膜的介电常数分别是2.85和2.94。     

含有吡啶环的可溶型聚苯并咪唑共聚物的合成及表征

采用溶液缩聚法合成了不同摩尔比的3,3′-二氨基联苯二胺（DAB）、2,3,5,6-四氨基吡啶（TAP）盐酸盐和4,4′-二羧基二苯醚（DCDPE）的共聚物。用红外光谱（FT-IR）、核磁共振氢谱（1H-NMR）、热重分析（TGA）以及电子拉力机对聚合物的结构和性能进行了表征。结果表明：共聚反应中,当TAP在两种胺类单体中的摩尔分数分别为0.1、0.2、0.3时,30 ℃的特性黏度对应为0.806、0.816、1.028 dL/g。共聚物在N,N-二甲基酰胺（DMF）、二甲基亚砜（DMSO）、N-甲基-2-吡咯烷酮（NMP）等极性溶剂和浓H2SO4中有良好的溶解性。3种单体可以在短时间内形成共聚产物,产物具有良好的成膜性、热稳定性和力学性能。     

一种新型聚酰亚胺离子型共聚物的合成与表征

以过氧化氢为氧化剂,在三氟乙酸中对2,6-二氯吡啶进行氧化,制备了2,6-二氯吡啶氮氧化物,该单体与4,4′-二巯基二苯砜、3,3′-二甲基-双(4-代酰亚胺)4,4′-二苯甲烷(4-BCPI) 通过亲核取代反应生成了含有离子基团的聚酰亚胺。采用红外分析（FT-IR）、黏度测试、溶解度实验、热失重分析（TGA）和示差扫描量热分析（DSC）等测试方法,对所合成的聚酰亚胺的结构与性能进行了表征。测试结果表明：该类聚酰亚胺在室温下不仅可溶于常用的极性非质子有机溶剂,也能溶于氯仿、吡啶等溶剂。此外,10%热失重温度高于430 ℃,玻璃化转变温度高于210 ℃。     

对苯二胺类与2,2′-二噻吩共轭共聚物的金属催化法合成与表征

以1,3-二(二苯基膦)丙烷二氯化镍(Ⅱ)作为催化剂,分别合成了2,2′-二噻吩与N,N′-二氯对苯醌二亚胺和2,5-二甲基-N,N′-二氯对苯醌二亚胺的共轭交替共聚物：聚（N,N′-对苯醌二亚胺-2,2′-二噻吩）和聚（2,5-二甲基-N,N′-对苯醌二亚胺-2,2′-二噻吩）。利用红外光谱、紫外可见光谱、循环伏安等测试方法对这2种共聚物进行了表征和性能研究。结果表明：这2种共聚物分别在263、315、410、261、321、403 nm处出现了紫外吸收峰,对苯二胺上的甲基对共聚物电化学活性具有一定的影响。     

短侧链可溶性聚酰亚胺的制备和表征

利用3种廉价易得的含短侧链（甲基或乙基）芳香族二胺单体分别与3,3′,4,4′-二苯甲醚四酸二酐（ODPA）进行溶液缩聚反应制备了聚酰胺酸,再在三乙胺催化、乙酸酐脱水作用下进行化学亚胺化反应,成功制备出聚酰亚胺（PI）。通过红外光谱（FT-IR）证明PI已经完全亚胺化。溶解性实验表明这3种PI具有优异的溶解性能,如：在极性非质子溶剂1-甲基-2-吡咯烷酮(NMP)、N,N-二甲基甲酰胺(DMF)、N,N-二甲基乙酰胺(DMAc)、二甲基亚砜(DMSO)乃至低沸点溶剂氯仿和四氢呋喃(THF)中都可以溶解。采用DSC、TG、频谱分析仪、交流耐压试验装置、电阻测量仪、万能电子拉力机等多种手段对PI薄膜进行了性能测试。结果表明这3种PI保持了优良的热性能、电性能、力学性能等。     

含叔丁基可溶性芳香聚酰胺的制备及其性能研究

采用含叔丁基二胺的单体3,3''-二叔丁基-4,4''-二氨基二苯基-4″-叔丁基苯基甲烷（TADBP）分别与萘-1,4-二甲酸、间苯二甲酸和4,4-二苯醚二甲酸3种二酸单体通过Yamazaki膦酰化法缩聚制得一系列新型可溶性芳香聚酰胺（PA）。通过FT-IR、¹H-NMR、TG、DSC等测试手段研究了含叔丁基芳香聚酰胺的结构与性能,以及聚合物结构对其溶解性能、热性能的影响。结果表明：PA具有优异的溶解性能,常温下不仅能溶于高沸点的N-甲基吡咯烷酮（NMP）、N,N-二甲基乙酰胺（DMAc）、N,N-二甲基甲酰胺（DMF）、二甲基亚砜（DMSO）等强极性溶剂中,加热条件下甚至能溶于四氢呋喃、氯仿、二氯甲烷等低沸点溶剂;同时,PA还具有良好的热性能,玻璃化转变温度（T_g）为188~193℃,氮气氛围下失重5%和10%时的热失重温度分别为391~416℃和404~437℃。     

4,4’-二(烷/芳氧基甲基)联苯的合成

以4,4’-二氯甲基联苯（4,4’-bis(chloromethye)-biphenye,BCMB）为原料,通过Williamson醚合成法制备了一系列4,4’-二（烷/芳氧基甲基）联苯。对化合物4,4’-二（甲氧基甲基）联苯、4,4’-二（丁氧基甲基）联苯以及4,4’-二（苯氧基甲基）联苯的合成工艺进行改进,缩短了反应时间,提高了收率,并在此基础上合成了一系列化合物。     

有机磷阻燃改性水性聚氨酯

以聚醚(N210)、异佛尔酮二异氰酸酯(IPDI)为基本单体,［（双（2羟乙基）氨基）甲基］磷酸二乙酯（FRC6）、一缩二乙二醇（EX）为扩链剂,二羟甲基丙酸（DMPA）为亲水扩链剂, 3（2氨乙基）氨丙基甲基二甲氧基硅烷（KH602）为后扩链剂,合成了一系列有机磷（P）阻燃改性的水性聚氨酯乳液。研究表明：随着FRC6用量的增加,聚氨酯（PU）的起始热分解温度降低,但热释放速率也降低,而PU的阻燃性能得到很大的提高。当FRC6中P的含量占预聚体的质量分数为2.31%时,其氧指数为28%,垂直燃烧测试显示PU的阻燃性能已达到UL94V2级。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Analysis of CK-19,PDX-1,Nestin,Ngn3 in different donor islet purity in rats

Objective: To investigate if there are the CK-19, PDX-1, Nestin, Ngn3 positive cells in the donor islets of different purity in rats. Methods: Thirty male adult SD rats were randomly divided into 3 groups. Islets were isolated using digestion by ductal injection of collagenase. Group Ⅰ (n=10): Separating cell preparations were not purified, Group Ⅱ(n=10): Islet sediment was purified with 25% Ficoll400 ,Group Ⅲ (n=10): Islet sediment was purified with 25% and 11% Ficoll-400. The levels of protein of CK-19, PDX-1, Nestin and Ngn3 were detected by immunohistochemistry and the mRNA of CK-19, PDX-1, Nestin, Ngn3 was amplified by RT-PCR. Results: After two different purification methods applied, three islet preparations of different purities were obtained. The difference of islet purity was significant among various groups (P＜0.05). Compared with group Ⅱ and group Ⅲ,the protein and mRNA of CK-19, PDX-1, Nestin,Ngn3 were both higher in group Ⅰ; group Ⅲ was poorly expressed. Conclusions: The three different islet purity donor islet have different CK-19, PDX-1, Nestin, Ngn3 positive cells within them, indicating that there are some islet stem cells in the purified donor islet.     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.